Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease
- PMID: 14715433
- DOI: 10.1007/BF03033159
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease
Abstract
Chronic vascular hypoperfusion induces oxidative stress and brain energy failure, and leads to neuronal death, which manifests as cognitive impairment and the development of brain pathology as in Alzheimer disease (AD). It is becoming more widely accepted that AD is characterized by impairments in energy metabolism. We hypothesize that hypoperfusion-induced mitochondrial failure plays a central role in the generation of reactive oxygen species, resulting in oxidative damage to brain cellular compartments, especially in the vascular endothelium and neuronal cell bodies in AD. All of these changes have been found to occur before pathology and coexist during the progression of AD. In this review we have summarized recent evidence and our own knowledge regarding the relationship between the hypoperfusion-induced vascular damage that initiates oxidative stress and mitochondrial abnormalities that appear to be a key target for the development of AD pathology. Future investigations into both the mechanisms behind amyloid beta (Abeta) deposition and the possible accelerating effects of environmental factors, such as chronic hypoxia/reperfusion may open the door for effective pharmacological treatments of AD. We hypothesize that an imbalance between endothelium derived vasoconstrictors and vasodilators, along with an antioxidant system deficiency and mitochondria lesions are prominent in AD. Future studies examining the importance of mitochondrial pathophysiology in different brain cellular compartments may provide insight not only into neurodegenerative and/or cerebrovascular disease pathobiology but may also provide targets for treating these conditions.
Similar articles
-
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.Neurol Res. 2003 Sep;25(6):665-74. doi: 10.1179/016164103101201977. Neurol Res. 2003. PMID: 14503022
-
Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.Mitochondrion. 2004 Sep;4(5-6):649-63. doi: 10.1016/j.mito.2004.07.018. Mitochondrion. 2004. PMID: 16120422
-
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.J Neurol Sci. 2005 Mar 15;229-230:285-92. doi: 10.1016/j.jns.2004.11.040. Epub 2004 Dec 23. J Neurol Sci. 2005. PMID: 15760652
-
Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.Int J Biochem Cell Biol. 2009 Oct;41(10):1989-2004. doi: 10.1016/j.biocel.2009.03.015. Epub 2009 Apr 5. Int J Biochem Cell Biol. 2009. PMID: 19703659 Review.
-
Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.Curr Neurovasc Res. 2013 Feb;10(1):76-80. doi: 10.2174/156720213804805972. Curr Neurovasc Res. 2013. PMID: 23151073 Review.
Cited by
-
Mitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies.Rev Diabet Stud. 2009 Winter;6(4):237-46. doi: 10.1900/RDS.2009.6.237. Epub 2009 Dec 30. Rev Diabet Stud. 2009. PMID: 20043036 Free PMC article.
-
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence.J Neuroinflammation. 2013 Dec 1;10:142. doi: 10.1186/1742-2094-10-142. J Neuroinflammation. 2013. PMID: 24289502 Free PMC article. Review.
-
Application of calibrated fMRI in Alzheimer's disease.Neuroimage Clin. 2017 May 16;15:348-358. doi: 10.1016/j.nicl.2017.05.009. eCollection 2017. Neuroimage Clin. 2017. PMID: 28560160 Free PMC article.
-
Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?J Alzheimers Dis. 2015;46(1):35-53. doi: 10.3233/JAD-142976. J Alzheimers Dis. 2015. PMID: 25720414 Free PMC article. Review.
-
Update on the pharmacological treatment of Alzheimer's disease.Curr Neuropharmacol. 2010 Mar;8(1):69-80. doi: 10.2174/157015910790909520. Curr Neuropharmacol. 2010. PMID: 20808547 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical